Nature Communications (Jul 2021)

The trans-omics landscape of COVID-19

  • Peng Wu,
  • Dongsheng Chen,
  • Wencheng Ding,
  • Ping Wu,
  • Hongyan Hou,
  • Yong Bai,
  • Yuwen Zhou,
  • Kezhen Li,
  • Shunian Xiang,
  • Panhong Liu,
  • Jia Ju,
  • Ensong Guo,
  • Jia Liu,
  • Bin Yang,
  • Junpeng Fan,
  • Liang He,
  • Ziyong Sun,
  • Ling Feng,
  • Jian Wang,
  • Tangchun Wu,
  • Hao Wang,
  • Jin Cheng,
  • Hui Xing,
  • Yifan Meng,
  • Yongsheng Li,
  • Yuanliang Zhang,
  • Hongbo Luo,
  • Gang Xie,
  • Xianmei Lan,
  • Ye Tao,
  • Jiafeng Li,
  • Hao Yuan,
  • Kang Huang,
  • Wan Sun,
  • Xiaobo Qian,
  • Zhichao Li,
  • Mingxi Huang,
  • Peiwen Ding,
  • Haoyu Wang,
  • Jiaying Qiu,
  • Feiyue Wang,
  • Shiyou Wang,
  • Jiacheng Zhu,
  • Xiangning Ding,
  • Chaochao Chai,
  • Langchao Liang,
  • Xiaoling Wang,
  • Lihua Luo,
  • Yuzhe Sun,
  • Ying Yang,
  • Zhenkun Zhuang,
  • Tao Li,
  • Lei Tian,
  • Shaoqiao Zhang,
  • Linnan Zhu,
  • Ashley Chang,
  • Lei Chen,
  • Yiquan Wu,
  • Xiaoyan Ma,
  • Fang Chen,
  • Yan Ren,
  • Xun Xu,
  • Siqi Liu,
  • Jian Wang,
  • Huanming Yang,
  • Lin Wang,
  • Chaoyang Sun,
  • Ding Ma,
  • Xin Jin,
  • Gang Chen

DOI
https://doi.org/10.1038/s41467-021-24482-1
Journal volume & issue
Vol. 12, no. 1
pp. 1 – 16

Abstract

Read online

COVID-19 is a critical public health threat, but molecular characterizations of patients’ immunity is still lacking. Here the authors collected blood from patients with various disease severity, and prefiltered to exclude selected comorbidity, to obtain genomic, transcriptomic, proteomic, metabolomic and lipidomic profiles to report a trans-omics landscape.